Göran Forsberg
Chief Executive Officer chez CANTARGIA AB
Fortune : 99 357 $ au 31/03/2024
Profil
Dr. Göran Forsberg is an Independent Director at Guard Therapeutics International AB and a Chief Executive Officer at Cantargia AB.
He is on the Board of Directors at Guard Therapeutics International AB.
Dr. Forsberg was previously employed as a Chief Business Officer & VP-Investor Relations by Active Biotech AB, a Non-Executive Director by Isogenica Ltd., a Head-Business Development & Investor Relation by Kabigen AB, and a Head-Business Development & Investor Relation by University of Adelaide.
He also served on the board at Actinova AB, Active Biotech Research AB and Active Security Trading AB.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CANTARGIA AB
0,17% | 19/01/2024 | 304 412 ( 0,17% ) | 99 357 $ | 31/03/2024 |
Postes actifs de Göran Forsberg
| Sociétés | Poste | Début |
|---|---|---|
| CANTARGIA AB | Chief Executive Officer | 09/07/2014 |
| GUARD THERAPEUTICS INTERNATIONAL AB | Director/Board Member | 29/05/2019 |
Anciens postes connus de Göran Forsberg
| Sociétés | Poste | Fin |
|---|---|---|
| Kabigen AB | Investor Relations Contact | - |
| University of Adelaide | Investor Relations Contact | - |
| Actinova AB | Director/Board Member | - |
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Director/Board Member | - |
| Active Security Trading AB | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| CANTARGIA AB | Health Technology |
| GUARD THERAPEUTICS INTERNATIONAL AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
| Kabigen AB | |
| Active Security Trading AB | |
Active Biotech Research AB
Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Health Technology |
| Actinova AB |
